R

Relmada Therapeutics
D

RLMD

0.29370
USD
-0.02
(-7.06%)
مغلق
حجم التداول
2,102
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
8,862,163
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Relmada Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous systemdiseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment ofdepression and other potential indications.